Viral vector vaccines are a promising modern immunological approach and are becoming an important tool for the development of vaccines against emerging and challenging pathogens. The main applications of viral vector vaccines are emerging infectious diseases and those so far not reliably prevented by traditional vaccination strategies. Viral vectors are one of the most important gene transduction tools in biomedical research. Viral vectors include adeno-associated viruses, adenovirus, lentivirus, etc. The most common cell lines used for the production of viral vector vaccines are human embryonic kidney (HEK) 293 cells and Vero cells. A variety of SKC600, SKC900 and other bioreactor devices can be applied in the production of viral vector vaccines, helping biomedical enterprises to easily adjust production capacity and providing support for the production of traditional vaccines and emerging vaccines using recombinant technology.
Submit your requirements